BMS 214662

Discontinued Product

BMS 214662 (Cat. No. 1444) has been withdrawn from sale for commercial reasons.
Description: Potent and selective farnesyl transferase inhibitor
Chemical Name: (3R)-2,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine-7-carbonitrile
Purity: ≥99% (HPLC)

Biological Activity for BMS 214662

Potent and selective farnesyl transferase inhibitor (IC50 = 1.35 nM). 1000-fold selective over GGT1 enzyme. Exhibits anti-tumour activity in vivo following oral administration.

Licensing Information

Sold with the permission of Bristol-Myers Squibb Company, subject to U.S. Patent No. 6,011,029 and other US and foreign patents.

Technical Data for BMS 214662

M. Wt 489.61
Storage Desiccate at RT
Purity ≥99% (HPLC)
CAS Number 195987-41-8

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for BMS 214662

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service

View Related Products by Product Action

View all Other Transferase Inhibitors

Keywords: BMS 214662, BMS 214662 supplier, Other, Transferases, Post-translational, Modifications, 1444, Tocris Bioscience

Citations for BMS 214662

Citations are publications that use Tocris products.

Currently there are no citations for BMS 214662.

Reviews for BMS 214662

There are currently no reviews for this product. Be the first to review BMS 214662 and earn rewards!

Have you used BMS 214662?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review